Results 191 to 200 of about 11,407 (210)

In Vitro Comparison of Aztreonam/Amoxicillin-Clavulanate Versus Aztreonam/Ceftazidime-Avibactam on Ceftazidime-Avibactam Resistant Stenotrophomonas maltophilia

Microbial Drug Resistance, 2022
We investigated the in vitro susceptibility of ceftazidime-avibactam (CZA) resistant Stenotrophomonas maltophilia to the associations aztreonam/amoxicillin-clavulanate (ATM-AMC) and ATM-CZA. Forty clinical isolates of S. maltophilia
Lise Crémet, Léo Joffraud, Emmanuel Eschapasse, Tiphaine Bihouée, Adrien Tissot, Sophie Gibaud, Elise Persyn   +6 more
openaire   +3 more sources

The activity of ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa

Infectious Diseases, 2021
To the Editor, In this journal attempts to circumvent carbapenem resistance of Pseudomonas aeruginosa were recently reported [1]. Among 28 clinical carbapenem-resistant isolates of P.
Carmen Antonia Sanches, Ito, Larissa, Bail, Lavinia Nery Villa Stangler, Arend, Keite da Silva, Nogueira, Felipe Francisco, Tuon   +4 more
openaire   +2 more sources

Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect

Clinical Microbiology and Infection, 2021
Claire Amaris Hobson, Olivier Tenaillon, André Birgy   +2 more
exaly  

Carbapenem-resistant Klebsiella pneumoniae meningitis and abscess treated with ceftazidime-avibactam

Enfermedades infecciosas y microbiologia clinica (English ed.), 2022
Mehmet Yasir, Pektezel, Ilkay, Isikay, Rahsan, Gocmen, Ahmet Cagkan, Inkaya   +3 more
openaire   +3 more sources

Ceftazidime/avibactam against drug-resistant Enterobacteriaceae

PharmacoEconomics & Outcomes News, 2019
openaire   +1 more source

P120 Detection of ceftazidime-avibactam resistance in Pseudomonas aeruginosa isolates

Journal of Cystic Fibrosis, 2020
D. Allen, L.J. Sherrard, G.G. Einarsson, D.F. Gilpin, J.P. McKenna, D.J. Fairley, J.S. Elborn, M.M. Tunney   +7 more
openaire   +1 more source

Emerging Ceftazidime-Avibactam Resistance in carbapenem resistant Pseudomonas aeruginosa

2023
TÜZEMEN, NAZMİYE ÜLKÜ, ERGÖNÜL, MEHMET ÖNDER, CAN, FÜSUN, ALP ÇAVUŞ, SEMA, ÖKTEM, İBRAHİM MEHMET ALİ, KUTLU, MURAT, KALELİ, İLKNUR, AZAP, ÖZLEM, AYDIN, MEHTAP, NALÇA ERDİN, BEGÜM, AZAP, ALPAY, KARAHAN, ZEYNEP CEREN, KARAOĞLAN, İLKAY, ZER, YASEMİN, AYGÜN, GÖKHAN, YAVUZ, SERAP, AKALIN, EMİN HALİS, MENEKŞE, ŞİRİN, ÖNAL, UĞUR, ÜNAL, UĞUR, ÖKSÜZ, LÜTFİYE, BEŞLİ, YEŞİM, KESKE, ŞİRAN, ÖZTÜRK, ŞERİFE BARÇIN, HAKYEMEZ, FATMA SENA, ŞANLI, ÖZLEM, METE, AYŞE ÖZLEM, AFŞARLAR, HANDE, ÜÇER, SENGÜL, GÜLTEN, EZGİ, ÇAĞLAR ÖZER, MERVE, SARI, NURAN, BENLİ, AYSUN, IRMAK, ÇAĞLAR, ATAÇ, NAZLI, COOPER, FRANCIS, EKİNCİ, GÜZ, BORAL, JALE, GÜCER, LAL SUDE, PINARLIK, FATİHAN   +39 more
openaire   +1 more source

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Clinical Infectious Diseases, 2016
Ryan K Shields, Ghady Haidar, Yohei Doi
exaly  

607: CEFTAZIDIME-AVIBACTAM AND AZTREONAM AGAINST MULTIDRUG- RESISTANT PSEUDOMONAS AERUGINOSA

Critical Care Medicine, 2020
Rebecca Toor, Esther Garcia
openaire   +1 more source

Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Ghady Haidar, Cornelius J Clancy, Liang Chen   +2 more
exaly